梅波利祖马布在慢性阻塞性肺病 (COPD) 中:生物疗法的新前沿
Arun Mukesh1, Konica Chittoria2, Ankur Sharma2,3
1Department of Anesthesiology and Critical Care, All India Institute of Medical Sciences (AIIMS), Kalyani, India.
Saudi journal of anaesthesia
|September 25, 2025
概括
梅波利祖马布是一种抗类蛋白-5 (IL-5) 生物药物,为患有异敏性炎症的慢性阻塞性肺病 (COPD) 患者提供了一种新的治疗方法. 它为那些经历频繁恶化尽管标准疗法的人提供了潜在的解决方案.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性阻塞性肺病 (COPD) 影响许多患者,尽管目前的治疗方法.
- 乙酸性炎症是COPD患者的一个子集的关键因素.
- 现有的吸入疗法并不能在所有COPD病例中完全预防恶化.
研究的目的:
- 审查梅波利祖马布在治疗COPD中的作用.
- 讨论梅波利祖马布的作用机制,临床疗效和安全性.
- 探索生物制剂在COPD管理中的未来潜力.
主要方法:
- 临床试验和研究的文献综述 关于mepolizumab对COPD的研究.
- 对药物向介质蛋白-5 (IL-5) 的机制的分析.
- 根据已公布的数据对安全性概况和患者结果的评估.
主要成果:
- 梅波利祖马布是一种抑制IL-5的单克隆抗体,已被批准用于特定的COPD患者.
- 临床试验证明了其在减少异性COPD恶化中的有效性.
- 这种药物具有普遍有利的安全性.
结论:
- 梅波利祖马布代表了COPD治疗eosinophilic表型的重大进展.
- 它为患有持续恶化的患者提供了有针对性的生物方法.
- 进一步的研究可能会扩大生物药物的使用,用于管理复杂的COPD病例.
相关概念视频
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
01:26COPD: Management Using Bronchodilators and Corticosteroids
734
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
734
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.6K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K
01:22Chronic Obstructive Pulmonary Disease
2.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.3K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K